A review of the direct costs of rheumatoid arthritis: Managed care versus fee-for-service settings

PharmacoEconomics

Volumn 19, Issue 8, 2001, Pages 811-818

  Lubeck, Deborah P ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; TUMOR NECROSIS FACTOR;

ARTHRALGIA; DISEASE DURATION; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH MAINTENANCE ORGANIZATION; HOSPITAL CARE; HOSPITAL COST; HOSPITALIZATION; HUMAN; JOINT DESTRUCTION; MANAGED CARE; MORBIDITY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; FEE-FOR-SERVICE PLANS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MANAGED CARE PROGRAMS; UNITED STATES;

EID: 0034872289     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200119080-00003     Document Type: Review

References (48)

1. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States
2. Reassessment of twelve traditional paradigms concerning the diagnosis, prevalence, morbidity and mortality of rheumatoid arthritis
3. The economic burden of musculoskeletal disorders in Canada is similar to that for cancer and may be higher
4. Relative importance of musculoskeletal disorders as a cause of chronic health problems, disability, and health care utilization: Findings from the 1990 Ontario health Survey
5. The economic impact of the rheumatic diseases in the United States
6. Rheumatoid arthritis: Focus on appropriate drug therapy
7. Long term health outcomes of patients with rheumatoid arthritis treated in managed care and fee-for-service practice settings
8. Severity of disability and duration of disease in rheumatoid arthritis
9. A comparison of the treatment of rheumatoid arthritis in health maintenance organizations and fee-for-service practices
10. The costs of rheumatoid arthritis: Absolute, incremental, and marginal estimates
11. An assessment of the annual and long-term direct costs of rheumatoid arthritis
12. The cost of rheumatoid arthritis
13. Costs attributable to arthritis: Implications of costs
14. Direct medical costs unique to people with arthritis
15. A multicenter study of hospitalization in rheumatoid arthritis: Effect of health care system, severity, and regional difference
16. A multicenter study of annual health service utilization and costs in rheumatoid arthritis
17. Survival, prognosis, and causes of death in rheumatoid arthritis
18. Correlates of functional disability in early rheumatoid arthritis: A cross-sectional study of 706 patients in four European countries
19. Anxiety and depression in patients with rheumatoid arthritis: A prospective study of 400 patients
20. Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis
21. Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies
22. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996
23. NSAID-associated gastropathy: Incidence and risk factor models
24. The relative toxicity of disease modifying anti-rheumatic drugs (DMARDs)
25. Challenging the therapeutic pyramid: A new look at treatment strategies for rheumatoid arthritis
26. How do health-maintenance organizations achieve their 'savings'?
27. Managed care plan performance since 1980: A literature analysis
28. Second thoughts about HMOs for Medicare patients
29. Medicaid and managed care
30. Comparison of health outcomes at a health maintenance organization with those of fee-for-service care
31. HMO vs. fee-for-service care of older persons with acute myocardial infarction
32. Primary care performance in fee-for-service and prepaid health care systems: Results from the Medical Outcomes Study
33. A randomized trial to evaluate the effectiveness of a Medicaid HMO
34. Ambulatory testing for capitation and fee-for-service patients in the same practice setting: Relationship to outcomes
35. Chronic disease and health system performance: Care of osteoarthritis across three health services
36. Health care utilization and outcomes among persons with rheumatoid arthritis in fee-for-service and prepaid group practice settings
37. Practice variation in rheumatologists' encounters with their patients who have rheumatoid arthritis
38. Assuring quality, information, and choice in managed care
39. Health insurance characteristics and health care evaluations among persons with rheumatic diseases in California
40. The impact of chronic disease
41. Costs and outcomes in rheumatoid arthritis and osteoarthritis
42. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: The importance of drug and surgery costs
43. The mortality of rheumatoid arthritis
44. The relationship between clinical activity and depression on rheumatoid arthritis
45. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: A 12-year study
46. Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis
47. A multicenter study of hospitalization in rheumatoid arthritis: Frequency, medical-surgical admissions, and charges